CORC

浏览/检索结果: 共9条,第1-9条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFR beta 期刊论文
CANCER BIOLOGY & THERAPY, 2006, 卷号: 5, 期号: 3, 页码: 323-330
作者:  Zhong, L;  Guo, XN;  Zhang, XH;  Sun, QM;  Tong, LJ
收藏  |  浏览/下载:15/0  |  提交时间:2019/01/08
In vitro pharmacological characterization of TKI-28, a broad-spectrum tyrosine kinase inhibitor with anti-tumor and anti-angiogenic effects 期刊论文
CANCER BIOLOGY & THERAPY, 2005, 卷号: 4, 期号: 10, 页码: 1125-1132
作者:  Guo, XN;  Zhong, L;  Tan, JZ;  Li, J;  Luo, XM
收藏  |  浏览/下载:11/0  |  提交时间:2019/01/08
Expression and purification of the catalytic domain of human vascular endothelial growth factor receptor 2 for inhibitor screening 期刊论文
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 卷号: 1722, 期号: 3, 页码: 254-261
作者:  Zhong, L;  Guo, XN;  Zhang, XH;  Wu, ZX;  Luo, XM
收藏  |  浏览/下载:8/0  |  提交时间:2019/01/08
Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 卷号: 12, 期号: 15, 页码: 4003-4008
作者:  He, XG;  Lu, W;  Jiang, XQ;  Cai, JC;  Zhang, XW
收藏  |  浏览/下载:11/0  |  提交时间:2019/01/08
Differentiation-inducing action of 10-hydroxycamptothecian on human hepatoma Hep G2 cells 期刊论文
ACTA PHARMACOLOGICA SINICA, 2000, 卷号: 21, 期号: 4, 页码: 364-368
作者:  Zhang, XW;  Jiang, JF;  Xu, B
收藏  |  浏览/下载:11/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace